Levetiracetam In Sodium Chloride Injection
Product Images NDC 0143-9282

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Levetiracetam In Sodium Chloride (NDC 0143-9282). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Levetiracetam In Sodium Chloride Injection Structural Formula (Levetiracetam In Sodium Chloride Injection 1)

Chemical structure of levetiracetam, showing its molecular framework including a pyrrolidone ring and substituents attached to the central carbon atom.*

FDA Label Image

Levetiracetam 1500mg Outer Bag (Levetiracetam In Sodium Chloride Injection 10)

Levetiracetam in 0.54% Sodium Chloride Injection 15 mg/mL (1,500 mg per 100 mL) intravenous infusion, 1 x 100 mL vial. Manufactured by Hikma Farmacêutica (Portugal) and distributed by Hikma Pharmaceuticals USA Inc. The label includes dosing details, storage recommendations, and cautions for use with plastic containers and dilution.*

FDA Label Image

Levetiracetam 1500 mg Carton (Levetiracetam In Sodium Chloride Injection 11)

Levetiracetam in 0.54% Sodium Chloride Injection, 15 mg/mL (1,500 mg per 100 mL) in intravenous infusion form. The label shows packaging of 10 single-dose 100 mL bags. It is labeled for intravenous infusion only and distributed by Hikma Pharmaceuticals USA Inc., with manufacturing in Portugal. Instructions include infusion over 15 minutes and storage conditions.*

FDA Label Image

Figure 1 (Levetiracetam In Sodium Chloride Injection 2)

A bar chart comparing the percentage of patients across three groups: Placebo (7.4%), Levetiracetam 1000 mg/day (37.1%), and Levetiracetam 3000 mg/day (39.6%). The y-axis represents the percentage of patients from 0% to 45%. Both Levetiracetam groups show statistically significant differences versus placebo, indicated by asterisks above the bars.*

FDA Label Image

Figure 2 (Levetiracetam In Sodium Chloride Injection 3)

Bar chart showing the percentage of patients for placebo and two dosages of Levetiracetam (1000 mg/day and 2000 mg/day). The y-axis represents the percentage of patients, while the x-axis lists placebo and Levetiracetam dosages with the number of patients for each group. The chart highlights statistically significant differences versus placebo.*

FDA Label Image

Figure 3 (Levetiracetam In Sodium Chloride Injection 4)

A bar graph comparing the percentage of patients between two groups: placebo (104 patients) and Levetiracetam 3000 mg/day (180 patients). The Levetiracetam group shows a higher percentage of approximately 39.4%, while the placebo group shows about 14.4%. A notation indicates the difference is statistically significant versus placebo.*

FDA Label Image

Figure 4 (Levetiracetam In Sodium Chloride Injection 5)

A bar graph comparing the percentage of patients between two groups: placebo and Levetiracetam. The placebo group (N=84) shows 45.2% of patients, while the Levetiracetam group (N=79) shows 72.2%, with a notation indicating statistical significance versus placebo. The y-axis represents the percentage of patients from 0% to 100%.*

FDA Label Image

Levetiracetam In 0.82% Sodium Chloride Injection 500 mg Per 100 mL Overwrap (Levetiracetam In Sodium Chloride Injection 6)

Label for Levetiracetam in 0.82% Sodium Chloride Injection 500 mg per 100 mL (5 mg/mL) intravenous infusion. The label includes instructions to tear at notch for opening, dosage form as injection, volume 100 mL, and Rx only designation. Manufactured by Hikma Farmacêutica (Portugal), distributed by Hikma Pharmaceuticals USA Inc. Additional storage and usage instructions are provided, including caution against plastic container use in series connections.*

FDA Label Image

Levetiracetam 500 mg Carton (Levetiracetam In Sodium Chloride Injection 7)

Label for Levetiracetam in 0.82% Sodium Chloride Injection, 500 mg per 100 mL (5 mg/mL) intravenous infusion. The product comes in 10 single-dose 100 mL bags. Labeler is Hikma Pharmaceuticals USA Inc. The label includes usage instructions, storage conditions, and manufacturer information from Portugal.*

FDA Label Image

Levetiracetam 1000mg Outer Bag (Levetiracetam In Sodium Chloride Injection 8)

Levetiracetam in 0.75% Sodium Chloride Injection, 1,000 mg per 100 mL (10 mg/mL) intravenous injection by Hikma Pharmaceuticals USA Inc. The label indicates a single 100 mL vial for intravenous infusion only, with instructions for use, storage conditions, and cautions. Manufactured by Hikma Farmacêutica in Portugal.*

FDA Label Image

Levetiracetam 1000 mg Carton (Levetiracetam In Sodium Chloride Injection 9)

Label for Levetiracetam in 0.75% Sodium Chloride Injection, 1,000 mg per 100 mL (10 mg/mL), intravenous infusion. The product is supplied as 10 single-dose 100 mL bags. Labeler is Hikma Pharmaceuticals USA Inc. The label includes dosage, storage, and handling instructions along with manufacturer information from Portugal.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.